Journal Information
Vol. 58. Issue 12.
Pages 840-842 (December 2022)
Share
Share
Download PDF
More article options
Vol. 58. Issue 12.
Pages 840-842 (December 2022)
Scientific Letter
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration
David G. Parra,
Corresponding author
david.parr@uhcw.nhs.uk

Corresponding author.
, Joanna Chorostowska-Wynimkob, Angelo Corsicoc, Cristina Esquinasd, Gerard N. McElvaneye, Annelot D. Sarkf, Maria Sucenag, Hanan Tanashh, Alice M. Turneri, Marc Miravitllesd
a Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
b Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Disease, Warsaw, Poland
c Respiratory Diseases Division, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy
d Pneumology Department, Hospital Universitari Vall d’Hebron/Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
e Irish Centre for Genetic Lung Disease, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland
f Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
g Pulmonology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal
h Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund University, Sweden
i Institute for Applied Health Research, University of Birmingham, Birmingham, UK
Ver más

Statistics

Follow this link to access the full text of the article

Scientific Letter
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration
David G. Parra,
Corresponding author
david.parr@uhcw.nhs.uk

Corresponding author.
, Joanna Chorostowska-Wynimkob, Angelo Corsicoc, Cristina Esquinasd, Gerard N. McElvaneye, Annelot D. Sarkf, Maria Sucenag, Hanan Tanashh, Alice M. Turneri, Marc Miravitllesd
a Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
b Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Disease, Warsaw, Poland
c Respiratory Diseases Division, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy
d Pneumology Department, Hospital Universitari Vall d’Hebron/Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
e Irish Centre for Genetic Lung Disease, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland
f Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
g Pulmonology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal
h Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund University, Sweden
i Institute for Applied Health Research, University of Birmingham, Birmingham, UK
Ver más
Read
1962
Times
was read the article
550
Total PDF
1412
Total HTML
Share statistics
Article information
ISSN: 03002896
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 July 24 4 28
2024 June 66 31 97
2024 May 99 34 133
2024 April 56 27 83
2024 March 53 12 65
2024 February 66 27 93
2024 January 48 23 71
2023 December 58 26 84
2023 November 39 17 56
2023 October 80 31 111
2023 September 59 28 87
2023 August 33 28 61
2023 July 43 23 66
2023 June 60 13 73
2023 May 57 15 72
2023 April 51 19 70
2023 March 82 26 108
2023 February 66 24 90
2023 January 80 48 128
2022 December 285 90 375
2022 October 1 1 2
2022 September 3 1 4
2022 July 3 2 5
Show all

Follow this link to access the full text of the article

Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?